TELA Bio (TELA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 28, 2025, to be held virtually at 10:00 AM Eastern Time.
Proxy materials and annual report for fiscal year ended December 31, 2024, are available online for review and voting.
Shareholders are encouraged to review all proxy materials before voting and can opt for electronic delivery to support environmental initiatives.
Voting matters and shareholder proposals
Election of three directors: Jeffrey Blizard, Vince Burgess, and Federica O'Brien.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.
Advisory vote on executive compensation and preferred frequency of future say-on-pay votes.
Amendment to the 2019 Equity Incentive Plan to increase authorized shares by 3,500,000 and remove the evergreen provision.
Amendment to the Certificate of Incorporation to limit officer liability as permitted by Delaware law.
Approval to adjourn the meeting if there are insufficient votes for Proposals 5 and 6.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR Proposals 2, 3, 5, 6, and 7, and 1 YEAR on Proposal 4.
Latest events from TELA Bio
- Strong product innovation and European growth position the company for profitability and market expansion.TELA
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase2 Feb 2026 - Q2 revenue up 11% to $16.1M; net loss widened; full-year growth guidance reaffirmed.TELA
Q2 20241 Feb 2026 - Q3 revenue rose 26% to $19M, with improved margins and strengthened liquidity.TELA
Q3 202415 Jan 2026 - Mesh market shift and operational gains set stage for robust growth and profitability.TELA
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - 2024 revenue rose 19%, with 2025 guidance targeting up to 27% growth despite sector risks.TELA
Q4 202425 Dec 2025 - Up to 2,000,000 shares registered for resale; proceeds from warrant exercise support corporate growth.TELA
Registration Filing16 Dec 2025 - Expanding sales force and innovative products set the stage for strong growth and market penetration.TELA
Piper Sandler 37th Annual Healthcare Conference4 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, equity plan, and charter amendments.TELA
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, equity plan, and officer liability.TELA
Proxy Filing2 Dec 2025